ATE96168T1 - Karzinoembryonisches antigen kodierende cdns. - Google Patents

Karzinoembryonisches antigen kodierende cdns.

Info

Publication number
ATE96168T1
ATE96168T1 AT87111168T AT87111168T ATE96168T1 AT E96168 T1 ATE96168 T1 AT E96168T1 AT 87111168 T AT87111168 T AT 87111168T AT 87111168 T AT87111168 T AT 87111168T AT E96168 T1 ATE96168 T1 AT E96168T1
Authority
AT
Austria
Prior art keywords
nucleic acid
cea
cdns
carcinoembryonic antigen
detecting
Prior art date
Application number
AT87111168T
Other languages
English (en)
Inventor
Thomas R Barnett
James J Elting
Michael E Kamarck
Original Assignee
Miles Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Miles Inc filed Critical Miles Inc
Application granted granted Critical
Publication of ATE96168T1 publication Critical patent/ATE96168T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • C07K16/3007—Carcino-embryonic Antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/40—Fusion polypeptide containing a tag for immunodetection, or an epitope for immunisation
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Medicinal Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Cell Biology (AREA)
  • Pathology (AREA)
  • Wood Science & Technology (AREA)
  • Oncology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Hospice & Palliative Care (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Microbiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
AT87111168T 1986-08-13 1987-08-03 Karzinoembryonisches antigen kodierende cdns. ATE96168T1 (de)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US89636186A 1986-08-13 1986-08-13
US1668387A 1987-02-19 1987-02-19
US6003187A 1987-06-19 1987-06-19
EP87111168A EP0263933B1 (de) 1986-08-13 1987-08-03 Karzinoembryonisches Antigen kodierende cDNS

Publications (1)

Publication Number Publication Date
ATE96168T1 true ATE96168T1 (de) 1993-11-15

Family

ID=27360631

Family Applications (1)

Application Number Title Priority Date Filing Date
AT87111168T ATE96168T1 (de) 1986-08-13 1987-08-03 Karzinoembryonisches antigen kodierende cdns.

Country Status (12)

Country Link
EP (1) EP0263933B1 (de)
JP (2) JP3253609B2 (de)
AT (1) ATE96168T1 (de)
AU (1) AU598573B2 (de)
DE (1) DE3787864T2 (de)
DK (1) DK173134B1 (de)
ES (1) ES2059330T3 (de)
FI (1) FI873478A7 (de)
IE (1) IE60279B1 (de)
IL (1) IL83484A (de)
NZ (1) NZ221385A (de)
ZA (1) ZA875951B (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5122599A (en) * 1986-08-13 1992-06-16 Molecular Diagnostics, Inc. CDNAS coding for members of the carcinoembryonic antigen family
JP2607492B2 (ja) * 1987-01-14 1997-05-07 サントリー株式会社 ヒト癌胎児性抗原
US4908417A (en) * 1988-05-17 1990-03-13 Sumitomo Chemical Company, Limited Thermosetting resin composition
JPH02107189A (ja) * 1988-05-25 1990-04-19 City Of Hope 癌胎児抗原フラグメント
EP0346702A3 (de) * 1988-06-16 1991-08-28 Miles Inc. Transfizierte Zellinien, die isolierte Gene der karzinoembryonale Antigenfamilie exprimieren
US5200316A (en) * 1990-02-15 1993-04-06 Miles Inc. Immunoassay methods using noncross reactive cea gene family members antibodies
CA2102623C (en) * 1991-05-06 2003-04-22 Jeffrey Schlom Recombinant virus expressing carcinoembryonic antigen and methods of use thereof
CA2116640A1 (en) * 1993-03-25 1994-09-26 Alexey Terskikh Carcinoembryonic antigen derivatives
US6001349A (en) * 1995-02-22 1999-12-14 Therion Biologics Corporation Generation of human cytotoxic T-cells specific for carcinoma self-associated antigens and uses thereof
WO2002070751A1 (en) * 2001-03-02 2002-09-12 University Of Pittsburgh Of The Commonwealth System Of Higher Education Pcr method
US8119352B2 (en) 2006-06-20 2012-02-21 Cepheld Multi-stage amplification reactions by control of sequence replication times
JP5779352B2 (ja) 2008-03-14 2015-09-16 サノフィ パスツール バイオロジクス リミテッド ライアビリティ カンパニー 複製欠損フラビウイルスワクチンおよびワクチンベクター
EP2652498B1 (de) 2010-12-16 2018-04-18 F.Hoffmann-La Roche Ag Diagnose und behandlungen im zusammenhang mit th2-hemmung
WO2014140938A2 (en) 2013-03-14 2014-09-18 Centre Hospitalier Universitaire Vaudois Immunological methods

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4180499A (en) * 1971-01-27 1979-12-25 Hoffmann-La Roche Inc. Carcinoembryonic antigens
US4228236A (en) * 1978-05-15 1980-10-14 Northwestern University Process of producing carcinoembryonic antigen
JP2507982B2 (ja) * 1984-04-10 1996-06-19 武田薬品工業株式会社 ヒト癌胎児性抗原反応性モノクロ―ナル抗体の製造法

Also Published As

Publication number Publication date
IE60279B1 (en) 1994-06-29
DE3787864D1 (de) 1993-11-25
DK420487D0 (da) 1987-08-12
AU7686887A (en) 1988-03-24
ES2059330T3 (es) 1994-11-16
IL83484A (en) 1993-01-31
JP3253609B2 (ja) 2002-02-04
DE3787864T2 (de) 1994-02-10
IE872161L (en) 1988-02-13
ZA875951B (en) 1988-02-19
NZ221385A (en) 1991-06-25
AU598573B2 (en) 1990-06-28
JPS63119681A (ja) 1988-05-24
JPH09136900A (ja) 1997-05-27
FI873478L (fi) 1988-02-14
FI873478A0 (fi) 1987-08-11
FI873478A7 (fi) 1988-02-14
EP0263933A1 (de) 1988-04-20
IL83484A0 (en) 1988-01-31
DK173134B1 (da) 2000-01-31
DK420487A (da) 1988-02-14
EP0263933B1 (de) 1993-10-20

Similar Documents

Publication Publication Date Title
EP0346710A3 (de) cDNAs, die für Mitglieder der Karzinoembryonalantigen-Familie kodieren
DK420487D0 (da) Nucleinsyresekvens, der koder for en carcinoembryonisk antigenpeptid-sekvens
NL300197I1 (de)
DK108589D0 (da) Chimere antistoffer rettet mod humant carcinoembryonalt antigen samt dna-sekvenser, der koder for saadanne antistoffer
AU5909386A (en) Diagnostic reagents based on unique sequences within the variable region of the t cell receptor and uses thereof
DK108189D0 (da) Chimere antistoffer rettet mod humant carcinoembryonalt antigen og metal-chelater samt dna-sekvenser, der koder for saadanne antistoffer
DE68905633D1 (de) Markierer der t-zelle aktivierung.
NO932890L (no) Strukturelt gen for pnumokokkisk protein
EP0307247A3 (en) A method for culturing recombinant cells
DE3585790D1 (de) Varicella-zoster-virus-dns-sequenzen, diese enthaltende vektoren und wirtzellen, uebereinstimmende polypeptide und diese enthaltende verbindungen.
EP0149548A3 (en) Nucleic acid encoding a t-cell antigen receptor polypeptide
ES8800266A1 (es) Un metodo para obtener un polipeptido complementario de al menos una porcion de un peptido o proteina original
CY1109653T1 (el) Κυτοκινες θηλαστικων που σχετιζονται με ιντερλευκινη-17. πολυνουκλεοτιδια που τις κωδικοποιουν. χρησεις
NZ502391A (en) Mammalian cytokine: interleukin-B30 and related reagents
ATE140030T1 (de) Antigene proteine und diese enthaltende impfstoffe zur verhütung von kokzidiose
GB8501473D0 (en) Cloned dna sequences
EP0152612A3 (en) Determination of fibrin with fibrin-specific antibodies
EP0293079A3 (de) Chlamydia-Vakzin
DK467888D0 (da) Fremgangsmaade til fiksering af et antigen eller antistof samt et protein paa en baerer, saaledes overtrukket baerer og dens anvendelse.
DK447083A (da) Dna, som koder for humant interferon-gamma, rekombinant-dna indeholdende denne dna, mikroorganisme indeholdende rekombinant-dna'en og fremgangsmaade til fremstilling af humant interferon-gamma-polypeptid
FI851373A7 (fi) Menetelmä glykosidisidoksiin perustuvan antigeenin valmistamiseksi.
GR3015074T3 (en) Recombinant treponema hyodysenteriae antigen and uses therefor.
FI870501A0 (fi) Menetelmä melanoomaan liittyvän p97-antigeenin antigeenisen sukulaispeptidin tai -proteiinin valmistamiseksi, sekä siinä käyttökelpoiset yhdistelmävirukset, yhdistelmävektorit ja isäntäsolut
NO871737D0 (no) Rekombinant virus, polypeptid samt dna molekyl med kodingssekvens for dette polypeptid.
DK171386D0 (da) Hepatitis b-overfladeantigen dannet ved rekombineret dna-teknik, vacciner, diagnostika, cellelinier og fremgangsmaader til dannelse af disse

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
EELA Cancelled due to lapse of time